Intramuscular ketamine therapy is emerging as a promising option for people living with treatment-resistant depression who have not found relief through traditional antidepressants or therapy alone. Administered directly into the muscle, this medically supervised approach works differently from conventional treatments by targeting the brain’s glutamate system, offering rapid symptom relief for some patients within hours or days.
For those who have struggled through multiple failed treatment attempts, understanding all available options is an important step toward finding the right path forward. If you or someone you love is navigating treatment-resistant depression, knowing what today’s mental health landscape offers can make all the difference.
How IM Ketamine Therapy Works for Depression
Unlike traditional antidepressants that target serotonin or dopamine, intramuscular ketamine works on the brain’s glutamate system, producing effects that can be felt much faster. Here is a closer look at how the process typically unfolds:
Before Treatment
- A thorough psychiatric and medical evaluation is completed to determine whether the patient is a candidate.
- Medical history, current medications, and prior treatment attempts are reviewed.
- A personalized treatment plan is developed in collaboration with the care team.
During Treatment
- Ketamine is injected directly into the muscle, typically in the arm or thigh.
- Sessions are conducted in a clinical setting under continuous medical supervision.
- Most sessions last between 45 minutes and one hour
- Patients may experience dissociative effects, altered perceptions, or a dream-like state during the session
- Vital signs are monitored throughout the entire process
After Treatment
- Patients remain under observation until the immediate effects wear off
- Driving is not permitted following a session, so transportation must be arranged in advance
- Many providers recommend a series of sessions over several weeks for sustained results
- Integration therapy or ongoing mental health support is often encouraged alongside ketamine and Spravato® treatment for recovery.
What Makes It Different
- Results can emerge within hours to days rather than the weeks that antidepressants typically require.
- It targets a different neurological pathway, making it an option when other treatments have not worked.
- It is not a standalone cure but is most effective as part of a broader mental health treatment plan.
Intramuscular Ketamine vs. Traditional Antidepressants
For decades, traditional antidepressants like SSRIs and SNRIs have been the first line of defense against depression. While they work well for many people, a significant portion of patients do not experience adequate relief even after trying multiple medications. This gap in treatment is where intramuscular ketamine has begun to draw serious attention from the mental health community.
The most notable difference between the two approaches is speed. Traditional antidepressants typically require four to six weeks before any meaningful symptom relief is felt, and adjusting dosages or switching medications can extend that timeline significantly. Ketamine, by contrast, has shown the ability to reduce depressive symptoms within hours or days of administration.
The two treatments also work through entirely different mechanisms. SSRIs and SNRIs gradually regulate serotonin and norepinephrine levels. Ketamine acts on the glutamate system, triggering a rapid neurological response that researchers believe helps restore synaptic connections affected by chronic depression.
It is worth noting that these approaches are not necessarily in competition with one another. Many patients are experiencing the benefits of ketamine therapy as a complement to existing treatment plans rather than a replacement, working closely with their care team to determine the right combination of support.
Mental Health Treatment That Works
Call 949-625-0564What our customers are saying
How Intramuscular Ketamine Is Dosed for Depression
Dosing for intramuscular ketamine is not a one-size-fits-all process. Treatment plans are carefully individualized based on a patient’s body weight, medical history, treatment goals, and response to initial sessions. A qualified medical provider oversees every aspect of the dosing protocol to ensure safety and effectiveness throughout the course of treatment.
Typical dosing considerations include:
- Doses are generally calculated based on body weight, commonly ranging from 0.5 mg/kg to 1.5 mg/kg, depending on the provider and patient profile
- Initial sessions often begin at a lower dose to assess tolerance before any adjustments are made
- A standard treatment course typically involves six sessions spread over two to three weeks
- Maintenance sessions may be recommended after the initial series, depending on how long symptom relief lasts
- The interval between sessions is adjusted based on the individual’s response and the treating provider’s clinical judgment.
Because ketamine carries a risk of misuse and psychological dependence with improper administration, strict medical oversight is a non-negotiable component of any legitimate treatment protocol. Patients should always seek care from a licensed and accredited provider when exploring this option.
How Effective Is Intramuscular Ketamine for Depression?
Research into ketamine as a treatment for depression and Spravato® dosing has grown substantially over the past two decades, and the findings have been encouraging for patients who have exhausted other options. Clinical studies have consistently shown that a meaningful percentage of treatment-resistant patients experience significant reductions in depressive symptoms following a structured course of treatment, with some reporting relief after just one or two sessions.
The rapid onset of results is one of the most clinically significant aspects of this approach. For patients experiencing severe depression or suicidal ideation, waiting weeks for a traditional antidepressant to take effect is not always a viable option. The faster-acting nature of intramuscular ketamine has made it a subject of growing interest among psychiatrists treating acute and difficult-to-manage cases.
That said, response rates vary from person to person, and not every patient achieves the same level of relief. Some individuals experience significant improvement lasting weeks or months, while others may find the effects shorter-lived and require ongoing maintenance sessions. Researchers are still working to understand better which patient profiles respond best and how to optimize long-term outcomes. What is clear is that for many people, it has opened a door that previously felt closed.
Key Takeaways on Intramuscular Ketamine
- It works differently from traditional antidepressants. Rather than targeting serotonin or dopamine like SSRIs and SNRIs, intramuscular ketamine acts on the brain’s glutamate system, restoring synaptic connections that chronic depression can damage over time.
- Speed is its biggest clinical advantage. While traditional antidepressants can take four to six weeks to produce results, ketamine has shown the ability to reduce depressive symptoms within hours or days, making it particularly relevant for severe or acute cases.
- Treatment is highly individualized and medically supervised. Dosing is based on body weight, medical history, and patient response, with a standard course typically involving six sessions over two to three weeks, all conducted under strict clinical oversight.
- It is not a replacement for broader mental health care. Ketamine therapy is most effective when used as part of a comprehensive treatment plan, and many providers encourage integration therapy or ongoing mental health support alongside sessions.
- Results are promising but vary by patient. Clinical studies show meaningful symptom relief for a significant portion of treatment-resistant patients, though response rates differ, and some individuals may require maintenance sessions to sustain long-term outcomes.
If you or someone you love is living with treatment-resistant depression and traditional approaches have not provided the relief you were hoping for, you do not have to keep searching alone. At Moment of Clarity, we understand how exhausting and isolating that journey can feel, and we are here to help you explore every option available to you. Whether you have questions about intramuscular ketamine or want to learn more about our outpatient mental health programs in Southern California, our compassionate team is ready to listen. Reach out to us today at 949-625-0564 and take the first step toward feeling like yourself again.
Resources
- NIH – Intramuscular ketamine in acute depression
- Yale Medicine – Ketamine for Depression
- Harvard Health Publishing – Ketamine for treatment-resistant depression
